Search for publications

Search results

4893 items matching your search terms.

The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols

Mercieca-Bebber, R. Friedlander, M. Kok, P. S. Calvert, M. Kyte, D. Stockler, M. King, M. T.
QUALITY OF LIFE RESEARCH, 2016     DOI:10.1007/s11136-016-1339-x

Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review

Mercieca-Bebber, R. Palmer, M. J. Brundage, M. Calvert, M. Stockler, M. R. King, M. T.
BMJ OPEN, 2016     DOI:10.1136/bmjopen-2015-010938

Social Dancing and Incidence of Falls in Older Adults: A Cluster Randomised Controlled Trial

Merom, D. Mathieu, E. Cerin, E. Morton, R. L. Simpson, J. M. Rissel, C. Anstey, K. J. Sherrington, C. Lord, S. R. Cumming, R. G.
PLOS MEDICINE, 2016     DOI:10.1371/journal.pmed.1002112

Phase II study of anastrozole in recurrent estrogen / progesterone positive endometrial cancer: the PARAGON trial—ANZGOG 0903

Mileshkin, L.R. Edmondson, R. J. O'Connell R, L. Sjoquist, K.M. Cannan, D. Jyothirmayi, R. Beale, P.J. Bonaventura, A. Goh, J.C. Hall, M. Clamp, A.R. Green, J.A. Lord, R. Scurry, J. Friedlander, M. Paragon Study Group,


Etiological associations and outcome predictors of acute electroencephalography in childhood encephalitis

Mohammad, S. S. Soe, S. M. Pillai, S. C. Nosadini, M. Barnes, E. H. Gill, D. Dale, R. C.
CLINICAL NEUROPHYSIOLOGY, 2016     DOI:10.1016/j.clinph.2016.07.014

Biomarker development targeting unmet clinical needs

Monaghan, P. J. Lord, S. J. St John, A. Sandberg, S. Cobbaert, C. M. Lennartz, L. Verhagen-Kamerbeek, W. D. Ebert, C. Bossuyt, P. M. Horvath, A. R. Test Evaluation Working Group of the European Federation of Clinical, Chemistry Laboratory, Medicine
CLINICA CHIMICA ACTA, 2016     DOI:10.1016/j.cca.2016.06.037

Do Dialysis Decision Aids Improve Treatment Decision-Making?

Morton, R.
PERITONEAL DIALYSIS INTERNATIONAL, 2016     DOI:10.3747/pdi.2016.00017

Supportive Care: Economic Considerations in Advanced Kidney Disease

Morton, R. L. Kurella Tamura, M. Coast, J. Davison, S. N.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016     DOI:10.2215/CJN.12651115

The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review

Morton, R. L. Schlackow, I. Mihaylova, B. Staplin, N. D. Gray, A. Cass, A.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2016     DOI:10.1093/ndt/gfu394

Conservative Management and End-of-Life Care in an Australian Cohort with ESRD

Morton, R. L. Webster, A. C. McGeechan, K. Howard, K. Murtagh, F. E. Gray, N. A. Kerr, P. G. Germain, M. J. Snelling, P.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016     DOI:10.2215/CJN.11861115

Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer

Moth, E. McLachlan, S. A. Veillard, A. S. Muljadi, N. Hudson, M. Stockler, M. R. Blinman, P.
LUNG CANCER, 2016     DOI:10.1016/j.lungcan.2016.02.009

Estimating the risk of severe chemotherapy toxicity in adults ≥65 years: comparing the CARG score with oncologists' estimates of toxicity

Moth, E. B. Kiely, B. E. Beale, P. Linton, A. Goodwin, A. Stockler, M. R. Stefanic, N. Martin, A. Naganathan, V. Blinman, P.


Anaphylaxis fatalities in Australia 1997 to 2013

Mullins, R. J. Liew, W. K. Wainstein, B. Barnes, E. H. Campbell, D. E.